| Literature DB >> 18036215 |
Philip J Van der Wees1, Erik J M Hendriks, Jan W H Custers, Jako S Burgers, Joost Dekker, Rob A de Bie.
Abstract
BACKGROUND: Clinical guidelines are considered important instruments to improve quality in health care. Since 1998 the Royal Dutch Society for Physical Therapy (KNGF) produced evidence-based clinical guidelines, based on a standardized program. New developments in the field of guideline research raised the need to evaluate and update the KNGF guideline program. Purpose of this study is to compare different guideline development programs and review the KNGF guideline program for physical therapy in the Netherlands, in order to update the program.Entities:
Mesh:
Year: 2007 PMID: 18036215 PMCID: PMC2228296 DOI: 10.1186/1472-6963-7-191
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Basic characteristics of guideline programs
| CBO [18] Dutch Institute for health care improvement | Netherlands | 1980 | > 50 |
| CSP [28] Chartered Society of Physiotherapy | England | 1998 | 5–10 |
| NHMRC [19] National Health and Medical Research Council | Australia | 1995 | 10–20 |
| NZGG [20] New Zealand Guidelines Group | New Zealand | 1998 | > 50 |
| SIGN [21] Scottish Intercollegiate Guidelines Network | Scotland | 1995 | > 50 |
| USPSTF [22,23] U.S. Preventive Services Task Force | USA | 1989 | > 50 |
Source: Burgers [6], added and updated with own data via handbooks and websites
Compliance to AGREE criteria of six guideline development programs
| 1. The overall objective(s) of the guideline is (are) specifically described. | + | + | + | + | + | + |
| 2. The clinical question(s) covered by the guideline is (are) specifically described. | + | + | + | + | + | + |
| 3. The patients to whom the guideline is meant to apply are specifically described. | + | + | + | + | + | + |
| 4. The guideline development group includes individuals from all the relevant professional groups. | + | + | + | + | + | - |
| 5. The patients' views and preferences have been sought. | + | + | + | + | + | - |
| 6. The target users of the guideline are clearly defined. | + | + | + | + | + | + |
| 7. The guideline has been piloted among target users. | - | + | - | + | - | - |
| 8. Systematic methods were used to search for evidence. | + | + | + | + | + | + |
| 9. The criteria for selecting the evidence are clearly described. | + | + | + | + | + | + |
| 10. The methods used for formulating the recommendations are clearly described. | + | + | + | + | + | + |
| 11. The health benefits, side effects and risks have been considered in formulating the recommendations. | + | + | + | + | + | + |
| 12. There is an explicit link between the recommendations and the supporting evidence. | + | + | + | + | + | + |
| 13. The guideline has been externally reviewed by experts prior to its publication. | + | + | + | + | + | + |
| 14. A procedure for updating the guideline is provided. | + | + | + | + | + | + |
| 15. The recommendations are specific and unambiguous. | + | + | + | + | + | + |
| 16. The different options for management of the condition are clearly presented. | + | + | + | + | + | + |
| 17. Key recommendations are easily identifiable. | + | - | + | + | + | + |
| 18. The guideline is supported with tools for application. | + | - | + | + | + | + |
| 19. The potential organizational barriers in applying the recommendations have been discussed. | + | + | + | + | + | + |
| 20. The potential cost implications of applying the recommendations have been considered. | + | + | + | + | + | + |
| 21. The guideline presents key review criteria for monitoring and/or audit purposes. | + | - | + | - | + | + |
| 22. The guideline is editorially independent from the funding body. | + | + | + | + | + | + |
| 23. Conflicts of interest of guideline development members have been recorded. | + | + | + | + | + | + |
Compliance to AGREE criteria of previous and updated KNGF guideline program
| 1. The overall objective(s) of the guideline is (are) specifically described. | + | + |
| 2. The clinical question(s) covered by the guideline is (are) specifically described. | + | + |
| 3. The patients to whom the guideline is meant to apply are specifically described. | + | + |
| 4. The guideline development group includes individuals from all the relevant professional groups. | + | + |
| 5. The patients' views and preferences have been sought. | + | + |
| 6. The target users of the guideline are clearly defined. | + | + |
| 7. The guideline has been piloted among target users. | - | - |
| 8. Systematic methods were used to search for evidence. | + | + |
| 9. The criteria for selecting the evidence are clearly described. | + | + |
| 10. The methods used for formulating the recommendations are clearly described. | - | + |
| 11. The health benefits, side effects and risks have been considered in formulating the recommendations. | - | + |
| 12. There is an explicit link between the recommendations and the supporting evidence. | - | + |
| 13. The guideline has been externally reviewed by experts prior to its publication. | + | + |
| 14. A procedure for updating the guideline is provided. | - | + |
| 15. The recommendations are specific and unambiguous. | - | + |
| 16. The different options for management of the condition are clearly presented. | + | + |
| 17. Key recommendations are easily identifiable. | - | + |
| 18. The guideline is supported with tools for application. | + | + |
| 19. The potential organizational barriers in applying the recommendations have been discussed. | + | + |
| 20. The potential cost implications of applying the recommendations have been considered. | - | + |
| 21. The guideline presents key review criteria for monitoring and/or audit purposes. | - | + |
| 22. The guideline is editorially independent from the funding body. | + | + |
| 23. Conflicts of interest of guideline development members have been recorded. | - | + |
Comparison of guideline programs
| CBO | CSP | NHMRC | NZGG | SIGN | USPSTF | |
| Central coordination of development and program | + | - | + | + | + | + |
| Endorsement of guidelines developed by others | - | + | + | + | - | - |
| Topics collected through open procedure | - | - | - | - | + | + |
| Criteria described for selection of topics | + | + | + | + | + | + |
| Quantitative studies considered for analysis | + | + | + | + | + | + |
| Qualitative studies considered for analysis | + | + | - | + | + | - |
| Evidence tables produced to critically appraise studies | + | + | + | + | + | + |
| Strength of evidence graded in levels of hierarchy | + | + | + | + | + | + |
| Recommendations graded in levels linked to evidence | + | + | + | + | + | + |
| Review by referees/stakeholders | + | + | + | + | + | + |
| Open meeting/conference | + | - | + | - | + | - |
| Consultation of practitioners (peers) | + | + | + | + | + | - |
| Draft guideline available on website for comments | + | - | - | - | + | - |
| Publication on website | + | + | + | + | + | + |
| Full guideline published | + | + | + | + | + | + |
| Summary published | + | - | - | + | + | + |
| Patient version published | - | - | - | + | - | - |
| Timescale for updating guidelines is stated | + | + | + | - | + | + |
| Procedure for updating provided | + | + | + | + | + | + |
| Steps in updating procedure described | + | - | + | - | + | + |
| Continuous updating procedure available | + | - | - | - | - | - |
Considered judgment to formulate recommendations
| CBO | Clinical relevance | Considered judgment is described after description of the evidence. Formulation of the recommendation is based on the evidence and the considered judgment. |
| CSP | Strength of evidence | Development group should discuss considerations. When possible quantitative analysis should be made to estimate relative risks and benefits. Guideline document should describe some of the discussion and clearly describe the link between evidence review and recommendations. |
| NHMRC | Applicability of the evidence | A balance sheet is described to balance benefits and harms. |
| NZGG | Volume of evidence | A considered judgment form is used to link clinical questions, evidence and recommendation. The development group needs to make a decision at the beginning of the process about how to resolve differences. |
| SIGN | Quantity, quality and consistency of evidence | Development group summarizes view of considered judgment using a form to record their main points. The level of evidence is assigned to the judgment and a graded recommendation is formulated. |
| USPSTF | Quality of studies, linkage to key question using 3 criteria (internal validity, external validity, consistency), linkage to entire preventive service | Guideline topic team assesses criteria using systematic methods and rating systems. Recommendations reflect primarily the state of evidence. Making recommendations is done with the understanding that clinicians and policymakers must still consider additional factors in making their own decisions. Setting priorities in clinical practice (e.g. based on resource requirements) are beyond the scope of the review. |
Updated Dutch program for guideline development in physical therapy
| 1. Structure and organization | Central professional organization in collaboration with other institutes. Mono-disciplinary development group (5–10 members). Small group (2–3) of employed staff within development group responsible for review of literature and actual writing of the guideline. Patients involved in external review group and focus groups. |
| 2. Preparation/initiation | Special interest groups can propose topics using application form. Procedure is described for prioritizing topics. Guideline committee selects. KNGF board makes final decision. Literature orientation on the subject. Barriers and needs of physiotherapists and patients are described in application form. |
| 3. Development | Literature search using systematic strategy. Systematic review or meta-analysis if no (recent) review is available. Quality of studies assessed using different tools for diagnosis, intervention and systematic reviews. Hierarchy of the evidence described in four levels according to Dutch consensus. Grading of recommendations in four levels. Standardized formulation of recommendations according to grading. Outline of guideline divided in physical therapy diagnosis and treatment based on clinical reasoning process. Use of International Classification of Functioning (ICF) as nomenclature. |
| 4. Validation | Draft guideline sent to group of peers to test practicality, clarity and acceptability. Draft guideline discussed in external review group (relevant health care professionals, patients, stakeholders). Separate check by patient advisory board. Final draft checked by Guideline Committee. Endorsement by KNGF. Test piloting after endorsement. |
| 5. Dissemination and Implementation | Four products: practice guideline, review of the evidence, summary (in flow chart), patient version. Publication as supplement of Dutch Journal for Physical Therapy. Sent to all members of KNGF. Translated into English. Publication on website. Implementation plan with every guideline. |
| 6. Evaluation and update | No later than 5 years after publication decision about update, based on new evidence, results from pilot, professional developments and developments in guideline methodology. Additional (systematic) review of literature. Weighing of the evidence and recommendations adjusted or added if necessary. |